1 / 8

Global Biosimilars/Follow-on-Biologics Market Size, Share

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020. Get Full Report at: http://www.researchbeam.com/biosimilars-market

BretSZavala
Download Presentation

Global Biosimilars/Follow-on-Biologics Market Size, Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) 2013-2020 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST

  2. ReportOverview Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020. Browse Complete Study Report at: http://www.researchbeam.com/biosimilars-market

  3. ReportOverview Regulations for biosimilars plays a vital role in maintaining the viability and balance between original and biosimilar products. Various regulatory authorities, namely EMA and the U.S. FDA are actively regulating the biosimilars market. Regulations in the European union are considered benchmark around the world, as the guidelines proposed are most stringent for validation and commercialization of biosimilars. High profitability is the attractive aspect that is enticing companies to invest in the biosimilars industry. Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, the European market has been maximizing on the biosimilars market. Asia-Pacific and LAMEA market would witness a substantial rise in the use of biosimilars, as the demand for cost effective treatment is growing due to the prevalence of chronic diseases.

  4. ReportOverview • Key Benefits • The study is segmented in a strategic divisions to gain deeper insights into the market dynamics and understand the competitive environment of the overall market • Financial market forecast is provided for the next eight years by considering 2013 as the base year • Comprehensive and quantitative data about changing market trends, intensifying competition and opportunities in biosimilars market are provided to make better business decisions • Porter’s Five Forces model and SWOT analysis of the overall market is provided to help stakeholders gain strategic insights of the market • Deep dive analysis of key market players and strategies adopted by them are expounded to provide valuable information on the top contenders in the market • Identification of key investment pockets for the biosimilars market is strategically dealt to assist the stakeholders

  5. ReportOverview • Key Deliverables • Global biosimilars/follow-on-biologics market is categorized into technology, product types, applications, services and geography. • MARKET BY TECHNOLOGY • Monoclonal Antibodies (MAb) Technology • Recombinant DNA Technology (rDNA technology) • Nuclear magnetic resonance (NMR) technology • Chromatography • Electrophoresis • Mass Spectrometry • Western Blotting • Bioassay • Enquire About Report: http://www.researchbeam.com/biosimilars-market/enquire-about-report

  6. Tables of Contents CHAPTER 1 INTRODUCTION 1.1 Key Benefits 1.2 Key Market Segment 1.3 Key Audiences 1.3.1 Research Methodology 1.3.2 Primary Research 1.3.3 Secondary Research 1.3.4 Analyst tools and models CHAPTER 2 EXECUTIVE SUMMARY 2.1 CXO perspective 2.2 Market beyond: what to expect by 2025 2.2.1 Moderate growth scenario 2.2.2 Rapid growth scenario 2.2.3 Diminishing growth scenario

  7. Similar Market Reports • Critical Pharmaceuticals Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile • http://www.researchbeam.com/critical-pharmaceuticals-limited-pharmaceuticals-and-healthcare-deals-and-alliances-profile-market • Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review • http://www.researchbeam.com/bristol-myers-squibb-company-bmy-financial-and-strategic-swot-analysis-review-market • Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015 • http://www.researchbeam.com/metastatic-hepatocellular-carcinoma-hcc-pipeline-review-h1-2015-market

  8. Contact Visit us at : http://www.researchbeam.com/biosimilars-market • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related